Webinar | Women’s Nutrition: Nourishing Womanhood From Pregnancy To Menopause
11 September | 12 PM ET: Register Now

Boomerang Medical

Boomerang Medical is a developer of bioelectronic medicine technology designed to advance the treatment of autoimmune diseases
2021
02-Oct
02-10
California, United States
  • Drug Delivery and Devices
  • Drug Discovery and Development
  • Personalized Medicine Technologies
  • Wearables

Innovation

Industry Problem

Autoimmune and inflammatory diseases often require long-term drugs that can have incomplete response or systemic side effects.

R&D Focus

Vagus-nerve stimulation and bioelectronic treatment of inflammatory disease.

Innovative Solution

Develops an implantable neuromodulation system intended to regulate inflammatory pathways through the vagus nerve.

Investment Funding

Last Funding Stage

Series A

Total Funding Amount

$18M

Last Funding Amount

$15M

Last Funding Date

11-01-2022

Startup Stage

Early Stage

Lead Investors

Hatteras Venture Partners, Fogarty Innovation, Arboretum Ventures

People

Founders

CEO

About

Boomerang Medical is a developer of bioelectronic medicine technology designed to advance the treatment of autoimmune diseases

Products

Product

Boomerang bioelectronic medicine platform for inflammatory and autoimmune diseases.

Star Product

Inflammatory-bowel-disease neuromodulation program, because it is the lead clinical indication.

Demo Product or Complete Product?

Clinical-development stage.

Future Plan

Investment Funding

$15 million Series A announced in 2022, bringing reported funding at that time to approximately $18 million.

Something missing or incorrect on this page? Help us enrich this information